SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-20-000716
Filing Date
2020-07-06
Accepted
2020-07-06 16:01:21
Documents
2
Group Members
BIHUA CHENCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LPCORMORANT PRIVATE HEALTHCARE FUND II, LPCORMORANT PRIVATE HEALTHCARE GP II, LLC

Document Format Files

Seq Description Document Type Size
1 schedule13g.htm SC 13G 108211
2 exhibit99-1.htm EX-99.1 5352
  Complete submission text file 0000929638-20-000716.txt   115581
Mailing Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472
Business Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc., (Subject) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91541 | Film No.: 201013504
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

IRS No.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G